Hologic (HOLX) Tops Q2 EPS by 1c; offers guidance

Hologic (NASDAQ: HOLX) reported Q2 EPS of $1.03, $0.01 better than the analyst estimate of $1.02. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1 billion.

GUIDANCE:

Hologic sees Q3 2025 EPS of $1.04-$1.07, versus the consensus of $1.10. Hologic sees Q3 2025 revenue of $1-1.01 billion, versus the consensus of $1.025 billion.

Hologic sees FY2025 EPS of $4.15-$4.25, versus the consensus of $4.26. Hologic sees FY2025 revenue of $4.05-4.1 billion, versus the consensus of $4.083 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
• Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral